11 – 20 of 27
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2007
-
Mark
Plasma levels of alpha1-antichymotrypsin and secretory leukocyte proteinase inhibitor in healthy and chronic obstructive pulmonary disease (COPD) subjects with and without severe alpha1-antitrypsin deficiency.
(
- Contribution to journal › Article
-
Mark
Serum and bronchial lavage fluid concentrations of IL-8, SLPI, sCD14 and sICAM-1 in patients with COPD and asthma
(
- Contribution to journal › Article
- 2006
-
Mark
Secreted leukocyte protease inhibitor is present in aqueous humours from cataracts and other eye pathologies.
(
- Contribution to journal › Article
- 2005
-
Mark
Prolastin, a pharmaceutical preparation of purified human alpha 1-antitrypsin, blocks endotoxin-mediated cytokine release
(
- Contribution to journal › Article
- 2004
-
Mark
αl-antitrypsin and its C-terminal fragment attenuate effects of degranulated neutrophil-conditioned medium on lung cancer HCC cells, in vitro
(
- Contribution to journal › Article
- 2003
-
Mark
Human mast cells decrease SLPI levels in type II - like alveolar cell model, in vitro.
(
- Contribution to journal › Article
- 2002
-
Mark
The presence of elafin, SLPI, IL1-RA and STNFalpha RI in head and neck squamous cell carcinomas and their relation to the degree of tumour differentiation.
(
- Contribution to journal › Article
- 2001
-
Mark
Secretory leukocyte protease inhibitor in punch biopsies from human colonic mucosa
(
- Contribution to journal › Article
- 1999
-
Mark
The effect of immediate-hypersensitivity reactions on the level of SLPI, granulocyte elastase, α1-antitrypsin, and albumin in nasal secretions, by the method of unilateral antigen challenge
(
- Contribution to journal › Article
-
Mark
Identification of SLPI (Secretory leukocyte protease inhibitor) in human mast cells using immunohistochemistry and in situ hybridisation
(
- Contribution to journal › Article